发明名称 Immunomodulatory compounds for the restoration of vitamin D sensitivity in vitamin D resistant tumor cells
摘要 Provided herein are methods of restoring vitamin D sensitivity in tumor cells that are vitamin D resistant. Also provided are methods of treating, preventing or managing cancer using an immunomodulatory compound in combination with a vitamin D agent. Pharmaceutical compositions and single unit dosage forms suitable for use in the methods provided herein are also disclosed.
申请公布号 US8841325(B2) 申请公布日期 2014.09.23
申请号 US201013511002 申请日期 2010.11.24
申请人 Celgene Corporation 发明人 Brosseau Carole;Bartlett Justin Blake;Dalgleish Angus George;Colston Kay Winifred;Galustian Christine
分类号 A61K31/45;C07D401/04 主分类号 A61K31/45
代理机构 Dorf & Nelson LLP 代理人 Dorf & Nelson LLP ;Locke, Esq. Scott D.
主权项 1. A method of treating, managing or breast cancer refractory to vitamin D treatment, which comprises administering to a patient having such cancer an amount of an immunomodulatory compound, or a pharmaceutically acceptable salt, or stereoisomer thereof, in combination with a vitamin D agent, wherein the immunomodulatory compound is 4-(amino)-2-(2,6-dioxo-(3-piperidyl))-isoindoline-1,3-dione, or a pharmaceutically acceptable salt, or stereoisomer thereof, or 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl) -piperidine-2,6-dione, or a pharmaceutically acceptable salt, or stereoisomer thereof.
地址 Summit NJ US